DOI QR코드

DOI QR Code

Long-term Prognosis in Hepatocellular Carcinoma Patients after Hepatectomy

  • Zhou, Lei (Department of Hepatobiliary Surgery, the First Affiliated Hospital, School of Medicine, Xi'an Jiao tong University) ;
  • Liu, Chang (Department of Hepatobiliary Surgery, the First Affiliated Hospital, School of Medicine, Xi'an Jiao tong University) ;
  • Meng, Fan-Di (Department of Hepatobiliary Surgery, the First Affiliated Hospital, School of Medicine, Xi'an Jiao tong University) ;
  • Qu, Kai (Department of Hepatobiliary Surgery, the First Affiliated Hospital, School of Medicine, Xi'an Jiao tong University) ;
  • Tian, Feng (Department of Hepatobiliary Surgery, the First Affiliated Hospital, School of Medicine, Xi'an Jiao tong University) ;
  • Tai, Ming-Hui (Department of Hepatobiliary Surgery, the First Affiliated Hospital, School of Medicine, Xi'an Jiao tong University) ;
  • Wei, Ji-Chao (Department of Hepatobiliary Surgery, the First Affiliated Hospital, School of Medicine, Xi'an Jiao tong University) ;
  • Wang, Rui-Tao (Department of Hepatobiliary Surgery, the First Affiliated Hospital, School of Medicine, Xi'an Jiao tong University)
  • Published : 2012.02.29

Abstract

Background: The hepatocellular carcinoma is very common in China. Our aim in this report was to investigate clinical and pathological factors based on the current decade data that could influence prognosis of HCC patients after hepatectomy. Methods: Between 2002 and 2009, all patients undergoing hepatectomy for HCC were followed up and reviewed retrospectively. Prognostic factors were studied by univariate and multivariate analysis, with Kaplan-Meier and Cox multivariate survival analyses. Results: Complete clinicopathologic and follow-up data were available for 114 patients. The estimated cumulative survival rates at 1, 3, and 5 yr were 84.6%, 60.2% and 51.8%, respectively. On univariate analysis, key prognostic factors were AFP level, GGT level, tumor size, number of tumors, portal vein invasion, liver cirrhosis status and TNM stage. In the multivariate analysis, tumor size, GGT level, liver cirrhosis status and portal vein invasion were significantly associated with patients' prognosis. Conclusion: Through follow-up of a relatively large cohort of Chinese patients, tumor size, GGT level, liver cirrhosis status, portal vein invasion were revealed as important factors for long-term survival after hepatectomy. Early diagnosis for tumor and the improvement of liver function before surgery are important ways to improve the prognosis.

Keywords

Hepatocellular carcinoma;hepatectomy;multivariate analysis;prognosis

References

  1. Altekruse SF, McGlynn KA, Reichman ME (2009). Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol, 27, 1485-91. https://doi.org/10.1200/JCO.2008.20.7753
  2. Colombo M, Sangiovanni A (2011). How I manage my patients with hepatocelluar carcinoma. Liver Int, 31, 145-50. https://doi.org/10.1111/j.1478-3231.2010.02381.x
  3. Eguchi S, Kanematsu T, Arii S, et al (2011). Recurrencefree survival more than 10 years after liver resection for hepatocelluar carcinoma. Br J Surg, 98, 552-7. https://doi.org/10.1002/bjs.7393
  4. Jarnagin WR (2010). Management of small hepatocellular carcinoma: a review of transplantation, resection, and ablation. Ann Surg Oncol, 17, 1226-33. https://doi.org/10.1245/s10434-010-0978-3
  5. Ju MJ, Qiu SJ, Fan J, et al (2009). Preoperative serum gamma-glutamyl transferase to alanine aminotransferase ratio is a convenient prognostic marker for Child-Pugh A hepatocellular carcinoma after operation. J Gastroenterol, 44, 635-42. https://doi.org/10.1007/s00535-009-0050-x
  6. Pawlik TM, Delman KA, Vauthey JN, et al (2005). Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transplantation, 11, 1086-92. https://doi.org/10.1002/lt.20472
  7. Peng W, Chen Y, Jiang Q, Zheng Y (2010). Spatial analysis of hepatocellular carcinoma and socioeconomic status in China from a population-based cancer registry. Cancer Epidemiol, 34, 29-33. https://doi.org/10.1016/j.canep.2009.12.013
  8. Ryder SD (2003). Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut, 52 , III1-81.
  9. Schiffman SC, Woodall CE, Kooby DA, et al (2010). Factors associated with recurrence and survival following sepatectomy for large hepatocellular carcinoma: a multicenter analysis. J Surg Oncol, 101, 105-10.
  10. Sumie S, Kuromatsu R, Okuda K, et al (2008). Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol, 15, 1375-82. https://doi.org/10.1245/s10434-008-9846-9
  11. Yao DF, Dong ZZ, Yao M (2007). Specific molecular markers in hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int, 6, 241-7.
  12. Yao D, Jiang D, Huang Z, et al (2000). Abnormal expressiom of hepatoma specific γ-glutamyl transferase and alteration of $\gamma$-glutamyl transferase gene methylation status in patients with hepatocellular carcinoma. Cancer, 88, 761-9. https://doi.org/10.1002/(SICI)1097-0142(20000215)88:4<761::AID-CNCR5>3.0.CO;2-5

Cited by

  1. Anticancer Activity of Acacia nilotica (L.) Wild. Ex. Delile Subsp. indica Against Dalton's Ascitic Lymphoma Induced Solid and Ascitic Tumor Model vol.13, pp.8, 2012, https://doi.org/10.7314/APJCP.2012.13.8.3989
  2. Bioinformatics Analysis Reveals Potential Candidate Drugs for HCC vol.19, pp.2, 2013, https://doi.org/10.1007/s12253-012-9576-y
  3. Activity and Expression Pattern of NF-κB/P65 in Peripheral Blood from Hepatocellular Carcinoma Patients - Link to Hypoxia Inducible Factor -1α vol.15, pp.16, 2014, https://doi.org/10.7314/APJCP.2014.15.16.6911
  4. Is Hepatectomy for Huge Hepatocellular Carcinoma (≥10cm in Diameter) Safe and Effective? A Single-center Experience vol.15, pp.17, 2014, https://doi.org/10.7314/APJCP.2014.15.17.7069
  5. Retrospective Evaluation of Discrepancies between Radiological and Pathological Size of Hepatocellular Carcinoma Masses vol.15, pp.21, 2014, https://doi.org/10.7314/APJCP.2014.15.21.9487
  6. PKM2 Regulates Hepatocellular Carcinoma Cell Epithelial-mesenchymal Transition and Migration upon EGFR Activation vol.15, pp.5, 2014, https://doi.org/10.7314/APJCP.2014.15.5.1961
  7. Predictive Value of Serum Insulin-like Growth Factor-1 in Hepatocellular Carcinoma vol.16, pp.2, 2015, https://doi.org/10.7314/APJCP.2015.16.2.613
  8. Combined measurements of tumor number and size helps estimate the outcome of resection of Barcelona clinic liver cancer stage B hepatocellular carcinoma vol.16, pp.1, 2016, https://doi.org/10.1186/s12893-016-0135-4
  9. The prognostic significance of pretreatment serum γ-glutamyltranspeptidase in primary liver cancer: a meta-analysis and systematic review vol.38, pp.6, 2018, https://doi.org/10.1042/BSR20181058